Pepticom joined The Alliance for Artificial Intelligence in Healthcare (AAIH)

The AAIH is a coalition of technology developers, pharmaceutical companies, and research organizations who share our goal of leveraging #AI to advance the quality of healthcare, with a special focus on AI-guided pharmaceutical development.Our advisor, Sarah Benson-Konforty, will attend our first AAIH Annual Members Meeting this May 17-18th in San Francisco.

Our CEO and co-founder, Dr. Immanuel Lerner will be speaking at TIDES Asia 2023

Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery. The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well […]

JP Morgan Healthcare Conference, San Francisco, January 9-10, 2023

The Pepticom Ltd. team, Our CEO Immanuel Lerner and Sarah Benson-Konforty, MD are attending the conference. You can meet them at our booth at the Health Innovation Lounge, the on-site hub of the Israeli health, tech & innovation community, and is located at 447 Sutter Street – a 2 min walk from the Westin St. Francis Hotel.